Joint ASTCT-EBMT Basic and Translational Scientific Meeting

The Joint ASTCT and EBMT Basic and Translational Scientific Meeting will be a 2.5-day conference focused on cutting-edge basic and translational biology in the field. The meeting will focus on fundamental themes and novel technologies with an emphasis on unpublished and innovative science. Attendance to the meeting will be limited to 120 attendees with afternoon breaks to allow for informal networking opportunities between junior and senior attendees. The meeting will host two days of poster sessions and a best oral abstract session.


Tuesday, May 23 - Friday, May 25, 2023
Eurostars Sitges
Av. Camí de Miralpeix, 12, 08870 Sitges, Barcelona
Sitges, Barcelona (Spain)


ASTCT and EBMT are soliciting abstracts that highlight the best of basic and translational science. Abstracts will be evaluated on their importance and relevance to the field, as well as originality and innovation in problem solving. Selected data and/or research will be showcased at the poster area. Moreover, top scoring abstracts will be selected as Oral Presentations and integrated in the program.

Submit Your Abstract


  • Opening Submission: December 21, 2022
  • Submission Deadline: March 18, 2023
  • Notification: TBD


  • Immune metabolism
  • GVHD
  • Stem cell biology
  • Cell engineering
  • Anti-leukemic strategies


ASTCT and EBMT have reserved rooms at a discounted rate at Eurostars Sitges Hotel. Information on how to make a hotel reservation will be distributed in the registration confirmation email.

Room Rate: 186.80€ Double room for Single Use/Night. Breakfast, VAT and local taxes included


The program is intended for both junior and senior members of the blood and marrow transplantation and cellular therapy field.

This conference is only for physicians and scientists who are currently practicing in the field of transplantation and cellular therapy and sponsoring companies. Please contact Yaiza Gonzalez if you are interested in participating as a sponsor.


Registration to this event is limited to a maximum of 120 total attendees. We are unable to accept additional registrants once the registration capacity has been met.




Junior Attendee Rate*


Senior Attendee Rate


*Junior attendees are defined as post doctoral fellows, current fellows, and junior faculty within the first three years of appointment.


Tuesday, May 23 

Time Session
9:00 - 9:15 AM Welcome and Introduction 

Immune Metabolism

Session Chair: Bruce Blazar, MD; University of Minnesota, US

9:15 - 9:45 AM Metabolic control of T cell differentiation in cancer

Greg Delgoffe, PhD; University of Pittsburgh, US
9:45 - 10:15 AM Metabolic reprogramming of T cells to enhance GVL effects

Prof. Dr. Robert Zeiser; University of Freiburg, DE
10:15 - 10:45 AM Obesity, inflammation and cancer

Jeffrey Rathmell, PhD; Vanderbilt University Medical Center, US
10:45 - 10:55 AM Oral Abstract Presentation
10:55 - 11:05 AM Oral Abstract Presentation
11:05 - 11:15 AM Oral Abstract Presentation
11:15 - 11:30 AM Break

Graft vs Host Disease 

Session Chair: Warren Schlomchik, MD; University of Pittsburgh, US

11:45 - 12:15 PM Target tissue: Tolerance and reminiscence

Pavan Reddy, MD; Baylor College of Medicine, US
12:15 - 12:45 PM T-cell Exhaustion and GVHD/GVL

Takanori Teshima, MD; Hokkaido University Hospital, JP
12:45 - 1:15 PM Anti-C19 CAR CD8 induced Tregs cell therapy to optimize GVHD/GVL outcome

Bruce Blazar, MD; University of Minnesota, US
1:15 - 1:25 PM Oral Abstract Presentation
1:25 - 1:35 PM Oral Abstract Presentation
1:35 - 1:45 PM Oral Abstract Presentation
1:45 - 5:30 PM Lunch + Afternoon Break
5:30 - 6:30 PM Poster Tour + Networking Hour
6:30 - 8:30 PM

Keynote Lecture and Dinner

Megan Skyes, MD; Columbia University Medical Center, US

Wednesday, May 24

Time Session

Stem Cell Biology

Session: Markus Manz, MD; University Hospital Zurich, CH

9:00 - 9:35 AM Harnessing the microenvironmental regulation for improved outcomes of HSCT

Markus Manz, MD; University Hospital Zurich, CH
9:35 - 10:10 AM The microbiome-IL-1 axis drives HSC inflamm-aging and clonal hematopoiesis 

Simón Méndez-Ferrer, PhD; University of Cambridge, UK

10:10 - 10:45 AM Non-genotoxic anti-CD117 antibody conditioning in hematopoietic stem cell transplantation 

Judith Shizuru, MD; Stanford University, US
10:45 - 11:00 AM Oral Abstract Presentation
11:00 - 11:30 AM Break

Cell Engineering 

Session Chair: Chiara Bonini, MD; I.R.C.C.S Ospedale San Raffaele, IT

11:30 - 12:05 PM CAR T cells for brain tumors

Crystal Mackall, MD; Stanford University, US
12:05 - 12:40 PM

The UCL CAR T programme: Better Targets, Better Targeting 

Claire Roddie, MD; University College London, UK

12:40 - 1:15 PM Modulating T cell memory and tumor glycosylation to improve CAR T cell therapy 

Monica Casucci, PhD; I.R.C.C.S Ospedale San Raffaele, IT
1:15 - 1:30 PM Oral Abstract Presentation
1:30 - 5:30 PM Lunch + Afternoon Break
5:30 - 6:30 PM Meet-the-Profession Session 
6:30 - 8:30 PM Keynote Lecture and Dinner

Luigi Naldini, MD, PhD; I.R.C.C.S Ospedale San Raffaele, IT

Friday, May 25

Time Session

Anti-Leukemic Strategies and NK Cells (Part I)

Session Chair: Nicolaus Kröger, MD; University Hospital Hamburg-Eppendorf, DE

9:00 - 9:30 AM Factors determining the transition from clonal hematopoiesis to myeloproliferative neoplasms and progression to myelofibrosis

Speaker: Prof. Dr. Radek Skoda; University Hospital Basel, CH
9:30 - 10:00 AM Off-The-Shelf targeted NK cell therapies to treat leukemia

Jeffrey Miller, MD; University of Minnesota, US
10:00 - 10:30 AM Effect of pre-leukemic mutations on hematopoietic stem cell and their progenies

Dominique Bonnet, PhD; Francis Crick Institute, UK
10:30 - 11:00 AM TCR-T cell therapy for leukemia post-transplantation 

Marie Bleakley, MD, PhD; Fred Hutchinson Cancer Center, US
11:00 - 11:30 AM Break

Anti-Leukemic Strategies and NK Cells (Part II)

Session Chair: Harry Dolstra, PhD; Radboud University Medical Centre, NL

11:30 - 12:00 PM Training NK cells for enhanced leukemia attack 

Todd Fehniger, MD, PhD; Washington University School of Medicine, US
12:00 - 12:30 PM Editing of T and HASC for improved CART function

John DiPersio, MD, PhD; Washington University School of Medicine, US
12:30 - 12:40 PM Oral Abstract Presentation
12:40 - 12:45 PM Closing Remarks